Sector Update: Health Care Stocks Flat to Lower Premarket Thursday
Incyte's and Syndax's Graft Disease Treatment Niktimvo Gets FDA Approval for Vial Sizes
Express News | Incyte Corp - Niktimvo Expected to Be Available in U.S. in Early February
Express News | Incyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (Axatilimab-Csfr) 9 Mg and 22 Mg Vial Sizes
Investing in Syndax Pharmaceuticals (NASDAQ:SNDX) Five Years Ago Would Have Delivered You a 53% Gain
Scotiabank Maintains Syndax Pharmaceuticals(SNDX.US) With Hold Rating, Cuts Target Price to $16
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
